Pharmacological Control of Output Flashcards

1
Q

What three things determine stroke volume?

A
  • preload - left ventricular end diastolic pressure
  • afterload - pressure in the wall of the left ventricle during ejection
  • inotropy - contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What determines contractility?

A

Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are inotopic drugs?

A

positive inotropic drugs = increase Ca = increase heart rate

negative inotropic drugs eg verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the three types of inotropic drugs?

A
  1. cardiac glycosides
  2. sympathomimetics
  3. phosphodiesterase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is an example of a cardiac glycoside?

A

digitalis

found in foxgloves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of digoxin?

A

inhibits Na/K ATPase = more Ca in cell = contraction increased

positive inotropism

it also blocks AV conduction, reducing HR by enhancing vagal nerve activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are uses of digoxin?

A
  • permanent/persistent atrial fibrillation (not first line)
  • first line for patients with AF who also have co-existing heart failure
  • if heart failure is due to left ventricular dysfunction and condition has worsened even after using ACEi, diuretics and beta blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are signs and symptoms of digoxin toxicity?

A
  • bradycardia
  • arrhythmia
  • nausea, vomiting
  • confusion
  • visual disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the dosing for digoxin?

A
  • high initial loading dose 5mcg/kg of lean body weight
  • maintenance dose calculated adjusted for renal function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the monitoring for digoxin?

A
  • to make toxicity isnt developing
  • monitor urea and electrolytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where are the a-receptors, b1-receptors and b2-receptors and what is their action?

A

a-receptors: in vasculature, agonists cause vasoconstriction

b1-receptors: expressed in heart, agonists are positively chronotropic

b2-receptors: vasculature, agonists cause vasodilatation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the use of dopamine

A

medium dose: b1 tachycardia and increased contraction

large doses: a effects = peripheral vasoconstriction

it is a sympathomimetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the function of Ad and NAd?

A

Ad: acts on all three receptors

used in cardiac arrest = peripheral vasoconstriction (a effects) and strong positive chronotropia (b1 effects)

NAd: a adrenoreceptor agonist -vasoconstrictor action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Talk about the use of phosphodiesterase inhibitors.

A

rarely used in clinical practise trials - increase in risk of mortality

used only in severe HF

eg enoximone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Whats the mechanism for phosphodiesterase inhibitors?

A

increase cAMP - increased contractility and heart rate

cAMP broken down by PDE

phospodiesterase inhibits breakdown of cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is inotropy and chronotropy?

A

inotropy - increeased contractility

chronotropy - increased heart arte

17
Q

What are the three types of HF?

A
  • HF caused by left ventricular systolic dysfunction LVSD
    • left ventricle becomes weak
  • HFpEF
    • left ventricle becomes stiff, difficult for heart chamber to fill with blood
  • HF caused by diseased or damaged valves
18
Q

What are symptoms of HF?

A
  • rapid weight gain
  • shortness of breath
  • increased welling in lower body
  • frequent dry, hacking cough
  • loss of appetite
19
Q

What is first line treatment for people with HFrEF?

A
  • ACEi
    • start at low dose and titrate upwards at short intervals until target dose reached
    • measure serum sodium and potassium, assess renal function before and to 2 weeks after starting and after each dose increment
    • take first dose at night and report troublesome dry cough
  • beta blockers
    • low dose, work upwards
    • side effects: fatigue, cold hands
    • do not stop taking